The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 272.00
Ask: 272.50
Change: -0.50 (-0.18%)
Spread: 0.50 (0.184%)
Open: 268.50
High: 273.00
Low: 268.50
Prev. Close: 273.00
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report - December 2023

12 Jan 2024 07:00

RNS Number : 4194Z
Ruffer Investment Company Limited
12 January 2024
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for December 2023.

 

http://www.rns-pdf.londonstockexchange.com/rns/4194Z_1-2024-1-11.pdf

 

Christmas arrived early for asset owners last year, as December saw US equities approach all-time highs and the bond rally continue. The Federal Reserve provided the festive cheer, by pivoting their message from 'higher for longer' interest rates to 'lower, sooner', projecting three cuts in 2024 thanks to falling inflation. This reinforced the market's soft-landing narrative and drove a US-centric Santa rally. Elsewhere, the Bank of Japan left policy unchanged despite significant noise, and investors remained unimpressed by the lack of concrete stimulus measures in China.

 

As was the case in November, the fund's fixed income holdings were the largest contributor - adding over 1.5% to performance. Yields continued to fall as the Chair of the Federal Reserve assured markets that they were unlikely to raise interest rates any further, taking the US ten year bond yield to 3.9%, down more than 1% since October. Our US exposure participated in the rally as the market broadened out from the 'Magnificent 7' technology stocks. Gold exposure was helpful, as the metal reached new highs. Meanwhile, the yen managed to gain over 4% against both the US dollar and the pound, despite the Bank of Japan leaving their loose monetary policy intact, adding over half a percent to performance in addition to gains from our yen call options. However, despite making positive returns in both December and the final quarter of 2023, the fund continued to face headwinds from its protective positions, which suffered as equities rose and credit spreads narrowed.

 

It continues to be our belief that tighter liquidity conditions present a significant risk to markets. Accordingly, we have reduced the fund's duration by roughly half from its recent peak, with sales of US bonds and gold bullion. This felt prudent given the bond market is now pricing six interest rate cuts in 2024, double the amount anticipated by the Fed. We believe a soft landing is now close to fully priced, leaving the market exposed to any pushback from policymakers or the data.

 

We maintain the view that it is too early to declare a soft-landing victory. Even if the probability of this outcome has increased, market pricing has moved even further, creating an asymmetry in asset prices. We think the scenario in which the market's six interest rate cuts are validated, is the arrival of recession. However, a soft landing is not an impossibility, and the fund holds over 20% across equities and commodities which should benefit from a broader market rally and further economic strength. This is also supported by the remaining fixed income positions and gold equities, which should rise in value if yields fall further.

 

Portfolio balance, which was painfully elusive at points last year, is now much more secure - evident in recent months as markets have rallied and the fund has delivered a positive return, despite its defensive positioning. Crucially though, if liquidity conditions and the economy do deteriorate, our derivative holdings - primarily credit protection and exposure to the VIX, should appreciate sharply. There were glimmers of this mid-month, as a small but sharp one day sell-off in the S&P saw the VIX index spike 12% intraday. 

 

Overall, we enter the new year with the mindset that we are continuing to travel towards the danger, rather than away from it, and we will not let a disappointing 2023 obscure what we see in front of us.

 

An error in calculation of the NAV total return since inception has led to the figure being understated by c 3% in the monthly reports published between July and December 2023. The performance methodology has been updated to remediate this error and the NAV total return since inception figure in this report is correct. Please note that this notice does not affect any of the published NAVs.

 

 

Enquiries:

Sanne Fund Services (Guernsey) Limited

Jamie Dodd

Email: RIC@apexfs.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAOURSVUAAAR
Date   Source Headline
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSMonthly Investment Report - April 2024
8th May 202412:21 pmRNSNet Asset Value(s)
1st May 20241:35 pmRNSNet Asset Value(s)
1st May 202411:36 amRNSTotal Voting Rights
24th Apr 20242:21 pmRNSNet Asset Value(s)
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20242:19 pmRNSNet Asset Value(s)
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20242:09 pmRNSNet Asset Value(s)
10th Apr 202410:31 amRNSMonthly Investment Report - March 2024
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20244:33 pmRNSDirector/PDMR Shareholding
9th Apr 20247:07 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20242:25 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:39 pmRNSNet Asset Value(s)
2nd Apr 202410:27 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:14 amRNSTransaction in Own Shares
27th Mar 20241:37 pmRNSNet Asset Value(s)
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20242:58 pmRNSNet Asset Value(s)
18th Mar 20247:30 amRNSRuffer LLP Senior Management Share Purchase
18th Mar 20247:15 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSNet Asset Value(s) (replacement)
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 202412:52 pmRNSNet Asset Value(s)
13th Mar 20247:30 amRNSBlock listing Interim Review
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSMonthly Investment Report - February 2024
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSKepler Trust Intelligence: New Research
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202411:47 amRNSNet Asset Value(s)
1st Mar 202412:04 pmRNSNet Asset Value(s)
1st Mar 202410:34 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSHalf-year Report
28th Feb 202412:11 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.